Home›Companies›Turn Biotechnologies

Turn Biotechnologies, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 6, 2023·Suggest an edit

About Turn Biotechnologies

Turn Biotechnologies is a private company based in Mountain View, California, incorporated in 2018 in Delaware. It has reported $29,132,219 raised in one offering on Form D since September 2023. Its chief executive is Anja Krammer.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 22, 2023Sep 6, 2023$29,132,219of $43.8M target55$529KEquity, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Turn Biotechnologies's Form D filed Sep 6, 2023.

MQ
Marco Quarta
Director
SC
Sergio Ruiz-Chinchilla
Executive officer
DG
David Gobel
Director
AK
Anja Krammer
Chief Executive Officer and director
RP
Ric Peterson
Executive officer

Sources

  1. SECTurn Biotechnologies, Inc. filing history